Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 9038-9048

  Tawaratsumida, Kazuki ^a   Van Phan, ^a,b   Hrincius, Eike R ^a   High, Anthony A ^a   Webby, Richard ^a   Redecke, Vanessa ^a   Häcker, Hans ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Proteomics Core Facility St Jude Children's Research Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; HOST FACTOR; INTERFERON; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; PROTEIN KINASE; PROTEIN PACT; PROTEOME; RETINOIC ACID INDUCIBLE PROTEIN I; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; GENE DELETION; GENE SILENCING; GENETIC CODE; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN RNA BINDING; PROTEIN TARGETING; PROTEOMICS; QUANTITATIVE ANALYSIS; VIRUS CELL INTERACTION; VIRUS RECOMBINANT; VIRUS REPLICATION; WILD TYPE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DEAD-BOX RNA HELICASES; DOGS; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS; INTERFERON-BETA; MADIN DARBY CANINE KIDNEY CELLS; PROMOTER REGIONS, GENETIC; PROTEOMICS; RNA, VIRAL; RNA-BINDING PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84904876332     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00830-14     Document Type: Article

References (44)

1. Hale BG, Randall RE, Ortin J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. The J. Gen. Virol. 89:2359-2376. http://dx.doi.org/10.1099/vir.0.2008/004606-0.
2. Egorov A, Brandt S, Sereinig S, Romanova J, Ferko B, Katinger D, Grassauer A, Alexandrova G, Katinger H, Muster T. 1998. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J. Virol. 72:6437-6441.
3. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, Summerfield A, Pavlovic J, Stech J, Staeheli P. 2007. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J. Gen. Virol. 88:1403-1409. http://dx.doi.org/10.1099/vir.0.82764-0.
4. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330. http://dx.doi.org/10.1006/viro.1998.9508.
5. Lu Y, Wambach M, Katze MG, Krug RM. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222-228. http://dx.doi.org/10.1006/viro.1995.9937.
6. Min JY, Krug RM. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2'-5' oligo( A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U. S. A. 103: 7100-7105. http://dx.doi.org/10.1073/pnas.0602184103.
7. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
8. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449. http://dx.doi.org/10.1016/j.chom.2009.04.006.
9. Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villan E, Garcia-Sastre A, Gack MU. 2012. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS pathogens 8:e1003059. http://dx.doi.org/10.1371/journal.ppat.1003059.
10. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. http://dx.doi.org/10.1038/nature05732.
11. Patel RC, Sen GC. 1998. PACT, a protein activator of the interferoninduced protein kinase, PKR. EMBO J. 17:4379-4390. http://dx.doi.org/10.1093/emboj/17.15.4379.
12. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379-390. http://dx.doi.org/10.1016/0092-8674(90)90374-N.
13. Gale M, Jr, Katze MG. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferoninduced protein kinase. Pharmacol. Ther. 78:29-46.
14. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. 2006. The role of PACT in the RNA silencing pathway. EMBO J. 25:522-532. http://dx.doi.org/10.1038/sj.emboj.7600942.
15. Kok KH, Lui PY, Ng MH, Siu KL, Au SW, Jin DY. 2011. The doublestranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9:299-309. http://dx.doi.org/10.1016/j.chom.2011.03.007.
16. Kew C, Lui PY, Chan CP, Liu X, Au SW, Mohr I, Jin DY, Kok KH. 2013. Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. J. Virol. 87:13141-13149. http://dx.doi.org/10.1128/JVI.02564-13.
17. Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF. 2013. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14:74-84. http://dx.doi.org/10.1016/j.chom.2013.06.010.
18. Dos Santos Afonso E, Escriou N, Leclercq I, van der Werf S, Naffakh N. 2005. The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5' end of the PB2 segment. Virology 341:34-46. http://dx.doi.org/10.1016/j.virol.2005.06.040.
19. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD. 2001. Analysis of the aphthovirus 2A/2B polyprotein "cleavage" mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal "skip." J. Gen. Virol. 82:1013-1025.
20. Brown LE, Hinshaw VS, Webster RG. 1983. Antigenic variation in the influenzaAvirus nonstructural protein, NS1. Virology 130:134-143. http://dx.doi.org/10.1016/0042-6822(83)90123-X.
21. van Wyke KL, Yewdell JW, Reck LJ, Murphy BR. 1984. Antigenic characterization of influenza A virus matrix protein with monoclonal antibodies. J. Virol. 49:248-252.
22. Becker-Hapak M, Dowdy SF. 2003. Protein transduction: generation of full-length transducible proteins using the TAT system. Curr. Protoc. Cell Biol. Chapter 20:Unit 20 22. http://dx.doi.org/10.1002/0471143030.cb2002s18.
23. Kok KH, Ng MH, Ching YP, Jin DY. 2007. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J. Biol. Chem. 282:17649-17657. http://dx.doi.org/10.1074/jbc.M611768200.
24. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 97:6108-6113. http://dx.doi.org/10.1073/pnas.100133697.
25. Cox J, Mann M. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26:1367-1372. http://dx.doi.org/10.1038/nbt.1511.
26. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289. http://dx.doi.org/10.1007/s007050170002.
27. Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, Ludwig S. 2007. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J. Virol. 81:3058-3067. http://dx.doi.org/10.1128/JVI.02082-06.
28. Neumann G, Hughes MT, Kawaoka Y. 2000. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J. 19:6751-6758. http://dx.doi.org/10.1093/emboj/19.24.6751.
29. Ong SE, Mann M. 2005. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1:252-262. http://dx.doi.org/10.1038/nchembio736.
30. Harsha HC, Molina H, Pandey A. 2008. Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nature protocols 3:505-516. http://dx.doi.org/10.1038/nprot.2008.2.
31. de Chassey B, Aublin-Gex A, Ruggieri A, Meyniel-Schicklin L, Pradezynski F, Davoust N, Chantier T, Tafforeau L, Mangeot PE, Ciancia C, Perrin-Cocon L, Bartenschlager R, Andre P, Lotteau V. 2013. The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLoS Pathog. 9:e1003440. http://dx.doi.org/10.1371/journal.ppat.1003440.
32. El Hefnawi M, Alaidi O, Mohamed N, Kamar M, El-Azab I, Zada S, Siam R. 2011. Identification of novel conserved functional motifs across most Influenza A viral strains. Virol. J. 8:44. http://dx.doi.org/10.1186/1743-422X-8-44.
33. Donelan NR, Basler CF, Garcia-Sastre A. 2003. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J. Virol. 77:13257-13266. http://dx.doi.org/10.1128/JVI.77.24.13257-13266.2003.
34. Lin L, Li Y, Pyo HM, Lu X, Raman SN, Liu Q, Brown EG, Zhou Y. 2012. Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. J. Virol. 86:1942-1954. http://dx.doi.org/10.1128/JVI.06362-11.
35. Wang X, Huang L. 2008. Identifying dynamic interactors of protein complexes by quantitative mass spectrometry. Mol. Cell. Proteomics 7:46-57. http://dx.doi.org/10.1074/mcp.M700261-MCP200.
36. Wuhr M, Haas W, McAlister GC, Peshkin L, Rad R, Kirschner MW, Gygi SP. 2012. Accurate multiplexed proteomics at the MS2 level using the complement reporter ion cluster. Anal. Chem. 84:9214-9221. http://dx.doi.org/10.1021/ac301962s.
37. Tan SL, Katze MG. 1998. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferoninduced PKR protein kinase. J. Interferon Cytokine Res. 18:757-766. http://dx.doi.org/10.1089/jir.1998.18.757.
38. Li S, Min JY, Krug RM, Sen GC. 2006. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13-21. http://dx.doi.org/10.1016/j.virol.2006.01.005.
39. Onomoto K, Jogi M, Yoo JS, Narita R, Morimoto S, Takemura A, Sambhara S, Kawaguchi A, Osari S, Nagata K, Matsumiya T, Namiki H, Yoneyama M, Fujita T. 2012. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 7:e43031. http://dx.doi.org/10.1371/journal.pone.0043031.
40. Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, Kumar A, Williams BR, Aguet M, Weissmann C. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:6095-6106.
41. Marie I, Durbin JE, Levy DE. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669. http://dx.doi.org/10.1093/emboj/17.22.6660.
42. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74:7989-7996. http://dx.doi.org/10.1128/JVI.74.17.7989-7996.2000.
43. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:5059-5064. http://dx.doi.org/10.1128/JVI.80.10.5059-5064.2006.
44. Wisskirchen C, Ludersdorfer TH, Muller DA, Moritz E, Pavlovic J. 2011. The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection. J. Virol. 85:8646-8655. http://dx.doi.org/10.1128/JVI.02559-10.